Painkilling drug shuts down cancer cell growth
June 15th, 2010 - 4:14 pm ICT by ANIWashington, June 15 (ANI): It has been previously observed that people who regularly take non-steroidal anti-inflammatory drugs (NSAIDs) like aspirin have lower incidences of certain types of cancer. Now, investigators at Sanford-Burnham Medical Research Institute (Sanford-Burnham) have figured out how one NSAID, called Sulindac, inhibits tumor growth.
The study reveals that Sulindac shuts down cancer cell growth and initiates cell death by binding to nuclear receptor RXRa, a protein that receives a signal and carries it into the nucleus to turn genes on or off.
“Nuclear receptors are excellent targets for drug development. Thirteen percent of existing drugs target nuclear receptors, even though the mechanism of action is not always clear,” said Xiao-kun Zhang, professor at Sanford-Burnham and senior author of the study.
RXRa normally suppresses tumors, but many types of cancer cells produce a truncated form of this nuclear receptor that does just the opposite. This study showed that shortened RXRa enhances tumor growth by stimulating other proteins that help cancer cells survive.
Luckily, the researchers also found that Sulindac can be used to combat this deviant RXRa by switching off its pro-survival function and turning on apoptosis, a process that tells cells to self-destruct.
Sulindac is currently prescribed for the treatment of pain and fever, and to help relieve symptoms of arthritis. The current study demonstrates a new application for Sulindac as a potential anti-cancer treatment that targets truncated RXRa protein in tumors.
However, some NSAIDs have gotten a lot of bad press for their potentially dangerous cardiovascular side effects. To overcome this limitation, the researchers tweaked Sulindac, creating a new version of the drug - now called K-80003 - that both decreases negative consequences and increases binding to truncated RXRa.
“Depending on the conditions, the same protein, such as RXRa, can either kill cancer cells or promote their growth. The addition of K-80003 shifts that balance by blocking survival pathways and sensitizing cancer cells to triggers of apoptosis,” Zhang said.
The study appears in Cancer Cell on June 15. (ANI)
- Cancer Cells May Kill Themselves On Taking A Painkiller - Jun 21, 2010
- Painkillers Can Make The Cancer Cells Kill Themselves - Jun 21, 2010
- Study: Painkillers may kill cancer cells too - Jun 21, 2010
- Biomarkers for particularly aggressive prostate cancers discovered - Jul 13, 2010
- Why Alzheimer's drug is both safe and effective - Aug 19, 2010
- Scientists convert skin cells to stem cells more effieciently - Feb 03, 2011
- Protein discovery could lead to better autoimmune disease, cancer drugs - Mar 03, 2011
- Heart hormone helps shape fat metabolism - Feb 07, 2012
- Marine sponges may help fight cancer - Feb 19, 2010
- New strategy to fight cancer drug resistance discovered - Jun 21, 2010
- New therapeutic target for lung cancer identified - Apr 01, 2011
- Burning more sugar drives super athleticism - Dec 01, 2011
- NSAIDs prevent colon cancer by causing stem cells to self-destruct - Nov 02, 2010
- Hormone pits fat against fat to reverse obesity - Oct 05, 2011
- How progesterone and estrogen increase breast cancer risk - Jan 19, 2011
Tags: anti inflammatory drugs, burnham, cancer cell growth, cardiovascular side effects, cell death, incidences, mechanism of action, medical research institute, negative consequences, new application, non steroidal anti inflammatory drugs, nsaids, nuclear receptor, nuclear receptors, sulindac, survival function, tumor growth, types of cancer, types of cancer cells, xiao